Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cortical circuit alterations precede motor impairments in Huntington's disease mice.

Burgold J, Schulz-Trieglaff EK, Voelkl K, Gutiérrez-Ángel S, Bader JM, Hosp F, Mann M, Arzberger T, Klein R, Liebscher S, Dudanova I.

Sci Rep. 2019 Apr 29;9(1):6634. doi: 10.1038/s41598-019-43024-w.

2.

Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.

Callahan JW, Abercrombie ED.

J Physiol. 2015 Aug 15;593(16):3727-38. doi: 10.1113/JP270268. Epub 2015 Jun 25.

3.

Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.

Murmu RP, Li W, Holtmaat A, Li JY.

J Neurosci. 2013 Aug 7;33(32):12997-3009. doi: 10.1523/JNEUROSCI.5284-12.2013.

4.

Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.

Farrar AM, Callahan JW, Abercrombie ED.

Exp Neurol. 2011 Dec;232(2):119-25. doi: 10.1016/j.expneurol.2011.08.010. Epub 2011 Aug 16.

PMID:
21864528
5.

Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease.

Miller BR, Walker AG, Barton SJ, Rebec GV.

Front Syst Neurosci. 2011 May 9;5:26. doi: 10.3389/fnsys.2011.00026. eCollection 2011.

6.

Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

Spampanato J, Gu X, Yang XW, Mody I.

Neuroscience. 2008 Dec 2;157(3):606-20. doi: 10.1016/j.neuroscience.2008.09.020. Epub 2008 Sep 18.

7.

Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.

Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ.

Eur J Neurosci. 2004 May;19(10):2799-807.

PMID:
15147313
8.

Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.

Samadi P, Boutet A, Rymar VV, Rawal K, Maheux J, Kvann JC, Tomaszewski M, Beaubien F, Cloutier JF, Levesque D, Sadikot AF.

Genes Brain Behav. 2013 Feb;12(1):108-24. doi: 10.1111/j.1601-183X.2012.00858.x. Epub 2012 Nov 21.

9.
10.

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.

Cummings DM, André VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS.

J Neurosci. 2009 Aug 19;29(33):10371-86. doi: 10.1523/JNEUROSCI.1592-09.2009.

11.

Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.

Murmu RP, Li W, Szepesi Z, Li JY.

J Neurosci. 2015 Jan 7;35(1):287-98. doi: 10.1523/JNEUROSCI.0244-14.2015.

12.

Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.

Khedraki A, Reed EJ, Romer SH, Wang Q, Romine W, Rich MM, Talmadge RJ, Voss AA.

J Neurosci. 2017 Aug 23;37(34):8077-8091. doi: 10.1523/JNEUROSCI.0313-17.2017. Epub 2017 Jul 19.

13.

Alterations in Hippocampal Inhibitory Synaptic Transmission in the R6/2 Mouse Model of Huntington's Disease.

Dargaei Z, Liang X, Serranilla M, Santos J, Woodin MA.

Neuroscience. 2019 Apr 15;404:130-140. doi: 10.1016/j.neuroscience.2019.02.007. Epub 2019 Feb 22.

PMID:
30797895
14.

Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington's disease.

Callahan JW, Abercrombie ED.

Neurobiol Dis. 2015 Jun;78:88-99. doi: 10.1016/j.nbd.2015.03.006. Epub 2015 Mar 12.

PMID:
25772440
15.
16.

Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.

Wade A, Jacobs P, Morton AJ.

Brain Res. 2008 Jan 10;1188:61-8. Epub 2007 Jul 14.

PMID:
18062944
17.

Exercise training normalizes mitochondrial respiratory capacity within the striatum of the R6/1 model of Huntington's disease.

Herbst EA, Holloway GP.

Neuroscience. 2015 Sep 10;303:515-23. doi: 10.1016/j.neuroscience.2015.07.025. Epub 2015 Jul 14.

PMID:
26186895
18.

Striatal pre-enkephalin overexpression improves Huntington's disease symptoms in the R6/2 mouse model of Huntington's disease.

Bissonnette S, Vaillancourt M, Hébert SS, Drolet G, Samadi P.

PLoS One. 2013 Sep 11;8(9):e75099. doi: 10.1371/journal.pone.0075099. eCollection 2013.

19.

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.

J Neurophysiol. 2006 Apr;95(4):2108-19. Epub 2005 Dec 28.

20.

Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.

Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M.

Neuroscience. 2009 Sep 29;163(1):456-65. doi: 10.1016/j.neuroscience.2009.06.014. Epub 2009 Jun 10.

PMID:
19524019

Supplemental Content

Support Center